Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-10-07

FDA Approved: BUPRENORPHINE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)

View source ↗

Summary

FDA approved a supplemental application for buprenorphine submitted by Hikma Pharmaceuticals USA Inc., authorizing changes to an approved generic product (ANDA …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • buprenorphine (buprenorphine)

Snippet

SUPPL AP for BUPRENORPHINE (BUPRENORPHINE)